• ALLIOSPHARMA resources are focused on lead selection, state-of-the-art development and positioning activities
• Pragmatic and balanced portfolio, with a good risk/reward ratio
• Selection of precise biological targets with significant unmet needs, in serious conditions with high prevalence and big public health concern.
• Pragmatic, multitechnology-driven, approach, without the constraints of one sole technologic platform and research center: multiple collaborations with high tech academic labs and private research companies, worldwide. |
|
